Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Substance-Related Disorders 1Pediatric Obesity 1Opioid-Related Disorders 1Lymphoma, Follicular 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ultrasonic Waves × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT05050539 2026-02-23

Adaptive Implementation to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings

University of Arkansas

Phase NA Active not recruiting
1,850 enrolled
Other

Pediatric Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡